- Home
- TANH vs QLGN Comparison
TANH vs QLGN Comparison
Compare TANH & QLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TANH
- QLGN
- Stock Information
- Founded
- TANH 2001
- QLGN 1996
- Country
- TANH China
- QLGN United States
- Employees
- TANH N/A
- QLGN N/A
- Industry
- TANH
- QLGN Biotechnology: Pharmaceutical Preparations
- Sector
- TANH
- QLGN Health Care
- Exchange
- TANH Nasdaq
- QLGN Nasdaq
- Market Cap
- TANH 2.8M
- QLGN 3.1M
- IPO Year
- TANH 2015
- QLGN N/A
- Fundamental
- Price
- TANH $1.81
- QLGN $1.90
- Analyst Decision
- TANH
- QLGN
- Analyst Count
- TANH 0
- QLGN 0
- Target Price
- TANH N/A
- QLGN N/A
- AVG Volume (30 Days)
- TANH 51.2K
- QLGN 116.2K
- Earning Date
- TANH 08-26-2025
- QLGN 08-26-2025
- Dividend Yield
- TANH N/A
- QLGN N/A
- EPS Growth
- TANH N/A
- QLGN N/A
- EPS
- TANH N/A
- QLGN N/A
- Revenue
- TANH $42,940,136.00
- QLGN N/A
- Revenue This Year
- TANH N/A
- QLGN N/A
- Revenue Next Year
- TANH N/A
- QLGN N/A
- P/E Ratio
- TANH N/A
- QLGN N/A
- Revenue Growth
- TANH N/A
- QLGN N/A
- 52 Week Low
- TANH $1.45
- QLGN $1.61
- 52 Week High
- TANH $10.77
- QLGN $11.50
- Technical
- Relative Strength Index (RSI)
- TANH 41.09
- QLGN 32.76
- Support Level
- TANH $1.77
- QLGN $1.61
- Resistance Level
- TANH $1.96
- QLGN $1.91
- Average True Range (ATR)
- TANH 0.12
- QLGN 0.16
- MACD
- TANH -0.01
- QLGN 0.02
- Stochastic Oscillator
- TANH 17.65
- QLGN 29.74
About TANH Tantech Holdings Ltd.
Tantech Holdings Ltd manufactures bamboo charcoal-based products. The company, through its subsidiaries, is engaged in the production and distribution of household products along with a trading business, which involves the export of charcoal products. It also manufactures electric double-layer capacitors carbon materials and low-emission barbecue charcoal. Its product portfolio includes air purifiers and humidifiers, underfloor humidity control, pillows and mattresses, wardrobe deodorizers, mousepads, and wrist mats, refrigerator deodorant, and charcoal toilet cleaner disks. The company has two reportable segments: the Consumer Product segment, and the Electric Vehicle (EV) segment.
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.